San Diego, CA, United States of America

Lawrence C Chew

This inventor holds 10 USPTO granted patents and 1 published patent application, plus 5 CIPO patents and 6 EPO patents. Top assignees: Pfenex Inc., Dow Global Technolgoies LLC. Active years: 2010-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lawrence C Chew. Retrieved from https://idiyas.com/inventor/lawrence-c-chew

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 70.0


 

Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 2010-2017

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: **Lawrence C Chew: Innovator in Recombinant Protein Production**

Introduction

Lawrence C Chew, an accomplished inventor based in San Diego, CA, has made significant contributions to the field of biotechnology. With a total of 10 patents to his name, his innovative work primarily focuses on the production of recombinant proteins, particularly in bacterial hosts. Lawrence’s inventions highlight the importance of developing efficient methods for protein expression, showcasing his commitment to advancing biotechnological methods.

Latest Patents

Among his latest patents, Lawrence developed a method for the production of recombinant proteins utilizing non-antibiotic selection methods. This invention provides compositions and methods for expressing nucleic acids that encode recombinant polypeptides and prototrophy-restoring enzymes in auxotrophic host cells. His approach introduces an analog into the growth media, improving recombinant protein expression compared to traditional antibiotic selection systems.

Another noteworthy patent involves a method for producing soluble recombinant interferon protein without denaturation. This invention addresses challenges in extracting soluble, active recombinant proteins from bacterial hosts by eliminating the need for denaturation and refolding steps. Specifically, it details a process to obtain high levels of soluble Type 1 interferon protein, marking a significant advancement in recombinant protein production.

Career Highlights

Lawrence has held key roles in prominent biotechnology companies, including Pfenex Inc. and Dow Global Technologies LLC. His experience in these organizations has undoubtedly shaped his innovative mindset, leading to groundbreaking advancements in the field of protein production.

Collaborations

Throughout his career, Lawrence has collaborated with notable professionals in the industry, such as Diane M Retallack and Keith L Haney. These partnerships have fostered a rich environment for creativity and innovation, further propelling his contributions to recombinant protein research.

Conclusion

Lawrence C Chew exemplifies the spirit of innovation in biotechnology through his impactful patents and collaborations. His work not only enhances recombinant protein production techniques but also contributes to the broader field of molecular biology, paving the way for future advancements in therapeutics and biotechnological applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…